Peter Bouwman
Leiden Amsterdam Centre for Drug Research
40 papers found
Refreshing results…
Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining
Download from doi.orgRadiosensitivity is an acquired vulnerability of PARPi-resistant BRCA1-deficient tumors
UploadBRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
UploadREV7 counteracts DNA double-strand break resection and affects PARP inhibition
Download from www.nature.comSuppression of BRCA1 sensitizes cells to proteasome inhibitors
Download from dx.doi.orgBRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres
Download from embojnl.embopress.orgMolecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?
Download from aacrjournals.orgMissing publications? Search for publications with a matching author name.